Literature DB >> 22991069

Neurological complications of hepatitis C infection.

Micheline McCarthy1, Melissa R Ortega.   

Abstract

Though well-known as a cause of liver disease, Hepatitis C virus infection is emerging as a cause of a variety of peripheral and central nervous system disorders. The virus causes chronic persistent infection with complex immune responses in the majority of individuals. Viral infection may have the potential to generate neurological illness through direct infection of neural cells or through immune-mediated mechanisms, including enhancement of autoimmune responses. Moreover, the mainstay of antiviral treatment of hepatitis C infection, interferon-alpha, is itself associated with neurological morbidity. Thus neurologists are increasingly faced with diagnosing or even predicting a wide spectrum of neurological complications of hepatitis C infection and/or its treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991069     DOI: 10.1007/s11910-012-0311-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  118 in total

Review 1.  Diagnostic tests for hepatitis C.

Authors:  J M Pawlotsky
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

2.  Dry cough and optic neuritis: two rare complications of interferon alpha treatment in chronic viral hepatitis.

Authors:  M Isler; G Akhan; Y Bardak; A Akkaya
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

3.  Hepatitis C virus and atherosclerosis in patients with type 2 diabetes.

Authors:  Michiaki Fukui; Yoshihiro Kitagawa; Naoto Nakamura; Toshikazu Yoshikawa
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

4.  Demyelinating lesions with features of Balo's concentric sclerosis in a patient with active hepatitis C and human herpesvirus 6 infection.

Authors:  D Ferreira; S Castro; G Nadais; J M Dias Costa; J M Fonseca
Journal:  Eur J Neurol       Date:  2010-09-16       Impact factor: 6.089

5.  Severe recurrent myelitis in patients with hepatitis C virus infection.

Authors:  K Marinou Aktipi; S Ravaglia; M Ceroni; R Nemni; M Debiaggi; S Bastianello; E Alfonsi; E Zardini; L Minoli; E Tavazzi; E Marchioni
Journal:  Neurology       Date:  2007-02-06       Impact factor: 9.910

6.  Hepatitis C associated with Guillain-Barré syndrome.

Authors:  F Lacaille; H Zylberberg; H Hagège; B Roualdès; C Meyrignac; M Chousterman; R Girot
Journal:  Liver       Date:  1998-02

7.  Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.

Authors:  Y S Huang; S J Hwang; C Y Chan; J C Wu; Y Chao; F Y Chang; S D Lee
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1999-06

8.  Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

Authors:  Charles L Raison; Andrey S Borisov; Sherry D Broadwell; Lucile Capuron; Bobbi J Woolwine; Ira M Jacobson; Charles B Nemeroff; Andrew H Miller
Journal:  J Clin Psychiatry       Date:  2005-01       Impact factor: 4.384

9.  Hepatitis C virus RNA localization in human carotid plaques.

Authors:  Maria Boddi; Rosanna Abbate; Benedetta Chellini; Betti Giusti; Carlo Giannini; Giovanni Pratesi; Luciana Rossi; Carlo Pratesi; Gian Franco Gensini; Laura Paperetti; Anna Linda Zignego
Journal:  J Clin Virol       Date:  2009-11-05       Impact factor: 3.168

Review 10.  Neurologic complications of hepatitis C.

Authors:  Jayant N Acharya; Vitor H Pacheco
Journal:  Neurologist       Date:  2008-05       Impact factor: 1.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.